IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v7y2016i1d10.1038_ncomms10369.html
   My bibliography  Save this article

Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination

Author

Listed:
  • Slim Fourati

    (Vaccine and Gene Therapy Institute of Florida
    University Hospitals of Cleveland and Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106, USA)

  • Razvan Cristescu

    (Merck Research Laboratories)

  • Andrey Loboda

    (Merck Research Laboratories)

  • Aarthi Talla

    (Vaccine and Gene Therapy Institute of Florida
    University Hospitals of Cleveland and Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106, USA)

  • Ali Filali

    (Vaccine and Gene Therapy Institute of Florida
    University Hospitals of Cleveland and Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106, USA)

  • Radha Railkar

    (Merck Research Laboratories)

  • Andrea K. Schaeffer

    (Merck Research Laboratories)

  • David Favre

    (Caprion/ImmuneCarta)

  • Dominic Gagnon

    (Caprion/ImmuneCarta)

  • Yoav Peretz

    (Caprion/ImmuneCarta)

  • I-Ming Wang

    (Merck Research Laboratories)

  • Chan R. Beals

    (Merck Research Laboratories)

  • Danilo R. Casimiro

    (Merck Research Laboratories)

  • Leonidas N. Carayannopoulos

    (Merck Research Laboratories)

  • Rafick-Pierre Sékaly

    (Vaccine and Gene Therapy Institute of Florida
    University Hospitals of Cleveland and Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106, USA)

Abstract

Aging is associated with hyporesponse to vaccination, whose mechanisms remain unclear. In this study hepatitis B virus (HBV)-naive older adults received three vaccines, including one against HBV. Here we show, using transcriptional and cytometric profiling of whole blood collected before vaccination, that heightened expression of genes that augment B-cell responses and higher memory B-cell frequencies correlate with stronger responses to HBV vaccine. In contrast, higher levels of inflammatory response transcripts and increased frequencies of pro-inflammatory innate cells correlate with weaker responses to this vaccine. Increased numbers of erythrocytes and the haem-induced response also correlate with poor response to the HBV vaccine. A transcriptomics-based pre-vaccination predictor of response to HBV vaccine is built and validated in distinct sets of older adults. This moderately accurate (area under the curve≈65%) but robust signature is supported by flow cytometry and cytokine profiling. This study is the first that identifies baseline predictors and mechanisms of response to the HBV vaccine.

Suggested Citation

  • Slim Fourati & Razvan Cristescu & Andrey Loboda & Aarthi Talla & Ali Filali & Radha Railkar & Andrea K. Schaeffer & David Favre & Dominic Gagnon & Yoav Peretz & I-Ming Wang & Chan R. Beals & Danilo R., 2016. "Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination," Nature Communications, Nature, vol. 7(1), pages 1-12, April.
  • Handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms10369
    DOI: 10.1038/ncomms10369
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms10369
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/ncomms10369?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Brad R Rosenberg & Marion Depla & Catherine A Freije & Denis Gaucher & Sabrina Mazouz & Maude Boisvert & Nathalie Bédard & Julie Bruneau & Charles M Rice & Naglaa H Shoukry, 2018. "Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance," PLOS Pathogens, Public Library of Science, vol. 14(9), pages 1-24, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms10369. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.